Integra LifeSciences (IART) Acquires Confluent Surgical Lines from Covidien (COV) for Up to $265M

October 28, 2013 5:18 PM

Integra LifeSciences Holdings (NASDAQ: IART) entered into a definitive agreement with Covidien (NYSE: COV) to acquire the Confluent Surgical product ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found